Page last updated: 2024-10-24

verapamil and Peripheral Arterial Diseases

verapamil has been researched along with Peripheral Arterial Diseases in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tebaldi, M1
Biscaglia, S1
Tumscitz, C1
Del Franco, A1
Gallo, F1
Spitaleri, G1
Fileti, L1
Serenelli, M1
Tonet, E1
Erriquez, A1
Campo, G1
Ferrari, R1

Trials

1 trial available for verapamil and Peripheral Arterial Diseases

ArticleYear
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study.
    Cardiology, 2018, Volume: 140, Issue:2

    Topics: Aged; Anticoagulants; Cardiac Catheterization; Double-Blind Method; Female; Heparin; Humans; Male; M

2018